NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
4.000
-0.170 (-4.08%)
Jan 30, 2026, 2:48 PM EST - Market open
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $329.51 million as of January 30, 2026. Its market cap has increased by 121.14% in one year.
Market Cap
329.51M
Enterprise Value
321.14M
1-Year Change
121.14%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from $37.55M to $329.51M, an increase of 777.55%. That is a compound annual growth rate of 37.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 345.53M | -22.50% |
| Dec 31, 2025 | 445.83M | 190.56% |
| Dec 31, 2024 | 153.43M | 25.91% |
| Dec 29, 2023 | 121.86M | 75.67% |
| Dec 30, 2022 | 69.37M | -29.11% |
| Dec 31, 2021 | 97.86M | 59.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NVIDIA | 4.53T |
| Alphabet | 3.98T |
| Apple | 3.76T |
| Microsoft | 3.42T |
| Amazon.com | 2.56T |
| Broadcom | 1.67T |
| Meta Platforms | 1.56T |
| Tesla | 1.46T |